DK355489A - USE OF SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANES FOR THE PREPARATION OF A MEDICINE AGAINST OBSTRUCTIVE FUNCTIONAL DISORDERS OF THE LUNGS AND / OR DISORDERS OF THE URINARY ROADS - Google Patents

USE OF SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANES FOR THE PREPARATION OF A MEDICINE AGAINST OBSTRUCTIVE FUNCTIONAL DISORDERS OF THE LUNGS AND / OR DISORDERS OF THE URINARY ROADS Download PDF

Info

Publication number
DK355489A
DK355489A DK355489A DK355489A DK355489A DK 355489 A DK355489 A DK 355489A DK 355489 A DK355489 A DK 355489A DK 355489 A DK355489 A DK 355489A DK 355489 A DK355489 A DK 355489A
Authority
DK
Denmark
Prior art keywords
disorders
alkyl
dihydro
substituted
urinary
Prior art date
Application number
DK355489A
Other languages
Danish (da)
Other versions
DK171782B1 (en
DK355489D0 (en
Inventor
Heinrich Christian Englert
Erik Klaus
Dieter Mania
Bernward Schoelkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK355489D0 publication Critical patent/DK355489D0/en
Publication of DK355489A publication Critical patent/DK355489A/en
Application granted granted Critical
Publication of DK171782B1 publication Critical patent/DK171782B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyrane Compounds (AREA)

Abstract

The use of 3,4-dihydro-2H-benzo[b]pyrans of the formula I <IMAGE> in which R<1> is H, OH, (C1-C2)-alkoxy, (C1-C2)-alkyl or NR<4>R<5>, where R<4> and R<5> are identical or different and are H, (C1-C2)-alkyl or (C1-C3)-alkylcarbonyl, R<2> and R<3> are identical or different and are alkyl with 1-4 C atoms, Ar is an aromatic or heteroaromatic system which is unsubstituted or substituted by 1 to 3 identical or different radicals (C1-C2)-alkyl, (C1-C2)-alkoxy, halogen, trifluoromethyl, CN, NO2, CO-(C1-C2)-alkyl or SOm-(C1-C2)-alkyl with m = 1 or 2, n is 1 or 2, X is a chain (CH2)r which can be interrupted by a heteroatom O, S or NR<6> where R<6> is H or (C1-C4)-alkyl and r is the numbers 2, 3, 4 or 5, for the production of a medicament for urinary tract disorders.
DK355489A 1988-07-19 1989-07-18 Use of 3,4-dihydro-2H-benzo [b] pyrans for the manufacture of a drug against obstructive pulmonary dysfunction DK171782B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3824446 1988-07-19
DE3824446A DE3824446A1 (en) 1988-07-19 1988-07-19 USE OF SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANE AS A MEDICINE AGAINST OBSTRUCTIVE FUNCTIONAL DISORDERS OF THE LUNG AND / OR DISORDERS OF THE LEADING URINE PATHS

Publications (3)

Publication Number Publication Date
DK355489D0 DK355489D0 (en) 1989-07-18
DK355489A true DK355489A (en) 1990-01-20
DK171782B1 DK171782B1 (en) 1997-05-26

Family

ID=6359009

Family Applications (1)

Application Number Title Priority Date Filing Date
DK355489A DK171782B1 (en) 1988-07-19 1989-07-18 Use of 3,4-dihydro-2H-benzo [b] pyrans for the manufacture of a drug against obstructive pulmonary dysfunction

Country Status (18)

Country Link
EP (2) EP0351720B1 (en)
JP (1) JPH0273015A (en)
KR (1) KR900001367A (en)
AT (1) ATE110270T1 (en)
AU (1) AU621388B2 (en)
CA (1) CA1336891C (en)
CZ (1) CZ417091A3 (en)
DE (2) DE3824446A1 (en)
DK (1) DK171782B1 (en)
ES (1) ES2061816T3 (en)
FI (1) FI893460A (en)
HU (1) HU210149B (en)
IE (1) IE63872B1 (en)
IL (1) IL91015A (en)
NZ (1) NZ229961A (en)
PH (1) PH26696A (en)
PT (1) PT91197B (en)
ZA (1) ZA895459B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW244350B (en) * 1991-12-14 1995-04-01 Hoechst Ag
TW316850B (en) * 1992-02-28 1997-10-01 Takeda Pharm Industry Co Ltd
HUT72741A (en) * 1992-12-19 1996-05-28 Alkaloida Vegyeszeti Gyar Method for producing benzopyrane derivatives and pharmaceutical compositions containing them
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
AU2273301A (en) 1999-12-23 2001-07-09 Robert E. Coifman Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer
KR100475147B1 (en) * 2002-09-09 2005-03-10 정의상 Remove noxious gas deodorant composite of alumina dust
AU2003274569B2 (en) 2002-11-12 2008-07-31 Warner-Lambert Company Llc Method of stimulating hair growth using benzopyrans

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3364734D1 (en) * 1982-10-19 1986-08-28 Beecham Group Plc Novel chromans and chromenes
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8513369D0 (en) * 1985-05-28 1985-07-03 Beecham Group Plc Treatment
EP0277611B1 (en) * 1987-02-04 1993-06-16 Hoechst Aktiengesellschaft Alkyl-substituted n-benzopyranyl lactames, process for their preparation, their use and pharmaceutical preparations on the basis of these compounds
DE3703227A1 (en) * 1987-02-04 1988-08-18 Hoechst Ag SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS

Also Published As

Publication number Publication date
CZ417091A3 (en) 1993-02-17
JPH0273015A (en) 1990-03-13
KR900001367A (en) 1990-02-27
IL91015A (en) 1994-11-28
HU210149B (en) 1995-02-28
FI893460A (en) 1990-01-20
NZ229961A (en) 1991-11-26
ATE110270T1 (en) 1994-09-15
ZA895459B (en) 1990-03-28
IE892323L (en) 1990-01-19
AU3818989A (en) 1990-01-25
EP0560399A1 (en) 1993-09-15
PH26696A (en) 1992-09-15
EP0351720A2 (en) 1990-01-24
AU621388B2 (en) 1992-03-12
EP0351720A3 (en) 1992-01-02
DK171782B1 (en) 1997-05-26
DK355489D0 (en) 1989-07-18
IE63872B1 (en) 1995-06-14
PT91197B (en) 1995-07-18
CA1336891C (en) 1995-09-05
DE3824446A1 (en) 1990-01-25
FI893460A0 (en) 1989-07-17
HUT55988A (en) 1991-07-29
PT91197A (en) 1990-02-08
DE58908228D1 (en) 1994-09-29
EP0351720B1 (en) 1994-08-24
ES2061816T3 (en) 1994-12-16

Similar Documents

Publication Publication Date Title
ES2037753T3 (en) HETERO-CYCLE COMPOUNDS AND THEIR PREPARATION AND USE.
DK355489D0 (en) USE OF SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANES FOR THE PREPARATION OF A MEDICINE AGAINST OBSTRUCTIVE FUNCTIONAL DISORDERS OF THE LUNGS AND / OR DISORDERS OF THE URINARY ROADS
FI940414A0 (en) Quinoline or quinazoline derivatives, their preparation and use
ES2061518T3 (en) COMPOUNDS THAT HAVE ANTITUMORAL AND ANTIBACTERIAL PROPERTIES.
IE880295L (en) Alkyl-substitued n-benzopyranyllactams
ATE207479T1 (en) CRYSTALS OF DERIVATIVES OF CHINOZONE CARBOXYLIC ACID HYDRATES
DK0528164T3 (en) Use of xanthine derivatives for the manufacture of a drug for the treatment of secondary nerve cell damage and functional disorders following skull-brain trauma
ATE92469T1 (en) NEW ALPHA-AMINOCARBONIC ACID DERIVATIVES, THEIR PREPARATION AND USE.
AU560141B2 (en) Piperazine derivatives of theophylline
DK342882A (en) THEOBROMINE DERIVATIVES
TR26593A (en) PROCEDURE FOR THE PRODUCTION OF HYDROPHIL STATUS TRIGLISERIDS.
DE59108921D1 (en) ACYL- (2&#39;-HYDROXYBIPHENYL-2-YL) PHOSPHINIC ACID SALTS, THEIR PRODUCTION AND USE
DK42481A (en) PROCEDURE FOR THE PREPARATION OF THEOPHYLLINE PIPERAZINE DERIVATIVES
ATE138914T1 (en) INDENO-D-PYRIMIDONE COMPOUNDS FOR USE IN MEDICINE
FI97883B (en) Process for the preparation of glycerol derivatives useful as a drug
ATE98235T1 (en) 2-THIAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM, PROCESSES FOR THEIR MANUFACTURE AND THEIR USE.
DK0631777T3 (en) Use of beta-naphtoquinone derivatives to inhibit platelet aggregation
PT88234A (en) PROCESS FOR THE PREPARATION OF CHLOROANILINE DERIVATIVES
ATE101115T1 (en) SALICYLATES, THEIR SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PROCESS OF MANUFACTURE.
DE69301639D1 (en) Tetrahydronaphthalene derivatives, their preparation and their therapeutic use
SE8901570D0 (en) ORGANIC SALTS OF CYSTEINE DERIVATIVES
PT97885A (en) (1-ARYL-2-PYRROLIDINYL) -METHYLPIPERAZINE DERIVATIVES AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE95697T1 (en) URICOSURETIC COMPOSITION.
IT1051359B (en) 2,2-Disubstd benzodioxoles - having antiinflammatory, analgesic, antitussive, CNS antiarrhythmic, and hypotensive properties
FI941850A (en) A new compound, leustroducsin H, its preparation and therapeutic use

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK